iVeena Delivery Systems Receives Notice of Allowance for Patent Protecting IVMED-10 & IVMED-20
SALT LAKE CITY--(BUSINESS WIRE)--iVeena Delivery Systems (iVeena), a biopharmaceutical company that develops innovative ophthalmology products, today announced that the United States Patent and Trademark Office (USPTO) communicated a Notice of Allowance for a patent assigned to the University of Utah and licensed to iVeena Delivery Systems Inc. The patent “Intraocular Drug Delivery Device and Associated Methods” covers methods to deliver dexamethasone to anterior and posterior eye segments to c